Search
-
Ipsos Launches AI-Powered Risk Informer for Real-Time, Project-Based Risk Monitoring
Discover How Our AI-Powered Platform Transforms Risk Management and Sustainability Compliance
-
Ipsos at the 2024 ESOMAR conference
Uncover the insights shared by our experts during the ESOMAR 2024 event.
-
Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.
-
Synthetic Data: From Hype to Reality - A Guide to Responsible Adoption
Synthetic data, powered by AI, is poised to transform the market research industry. The question isn’t if, but when and how. Recognizing the potential, but also the possible pitfalls, of the issue, our clients asked us to provide Ipsos’ trusted perspective on the topic.
-
A Dose of Digital: Can Pharma Make DTx a Healthy Business?
Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.
-
AI's transformative influence: Elevating market research quality for success
In the fast-paced world of business, having precise and top-quality information is like having a valuable asset. Artificial Intelligence (AI) is the key to making this information even better.
-
The role of Multifactor Authentication in reliable research
Maintaining high-quality panels is a crucial aspect of market research, as it directly impacts the reliability and accuracy of insights. See how Ipsos is taking proactive measures to uphold research standards.
-
Brand leaders share top tips for scaling social intelligence
Synthesio expert shares social intelligence program best practices and mistakes to avoid .